title: Alendronate sodium.
abstract: This chapter is a review on physical and chemical properties, methods of preparation, analysis, as well as pharmacodynamics and pharmacokinetics of Alendronate sodium (4-amino-1-hydroxybutane-1,1-diphosphonic acid sodium salt), a bone metabolism regulator, indicated for the treatment of excessive bone resorption and osteoporosis.
authors.affiliation: Apotex Inc., Toronto, Ontario, Canada.
authors.forename: Gennady
authors.initials: G
authors.lastname: Ananchenko
authors.forename: Jasmina
authors.initials: J
authors.lastname: Novakovic
authors.forename: Anna
authors.initials: A
authors.lastname: Tikhomirova
mesh_terms: D019386:Alendronate / Q000032:analysis / Q000138:chemical synthesis / Q000737:chemistry* / Q000493:pharmacokinetics; D000818:Animals; D050071:Bone Density Conservation Agents / Q000737:chemistry*; D003461:Crystallography; D006801:Humans; D012995:Solubility; D009626:Terminology as Topic
chemical_list: D050071:Bone Density Conservation Agents; D019386:Alendronate